FIA
FNY Investment Advisers Portfolio holdings
AUM
$235M
1-Year Return
45.4%
This Quarter Return
+2.64%
1 Year Return
+45.4%
3 Year Return
+178.61%
5 Year Return
+302.44%
10 Year Return
–
AUM
$193M
AUM Growth
-$14.2M
(-6.8%)
Cap. Flow
-$13.6M
Cap. Flow
% of AUM
-7.05%
Top 10 Holdings %
Top 10 Hldgs %
23.69%
Holding
990
New
273
Increased
128
Reduced
114
Closed
304
Top Buys
| 1 |
Humana
HUM
|
+$6.81M |
| 2 |
ASML
ASML
|
+$6.57M |
| 3 |
Vornado Realty Trust
VNO
|
+$4.02M |
| 4 |
SMAR
Smartsheet Inc.
SMAR
|
+$3.93M |
| 5 |
CME Group
CME
|
+$3.83M |
Top Sells
| 1 |
Illinois Tool Works
ITW
|
+$11.1M |
| 2 |
Altria Group
MO
|
+$7.08M |
| 3 |
FMC
FMC
|
+$5.43M |
| 4 |
Micron Technology
MU
|
+$4.36M |
| 5 |
Eli Lilly
LLY
|
+$3.74M |
Sector Composition
| 1 | Technology | 27.97% |
| 2 | Financials | 11.65% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 7.57% |
| 5 | Industrials | 5.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
AdvisorShares MSOS 2X Daily ETF
MSOX
$52.6M
| $45K | 0.02% |
+5,000
| New | +$45K |
|
327
Pacific Biosciences
PACB
$375M
| $45K | 0.02% |
+25,000
| New | +$45K |
|
328
PIMCO Corporate & Income Opportunity Fund
PTY
$2.68B
| $45K | 0.02% |
3,200
| – | – |
|
329
ESSA Pharma
EPIX
$11.2M
| $44K | 0.02% |
+25,000
| New | +$44K |
|
330
Helen of Troy
HELE
$563M
| $44K | 0.02% |
+750
| New | +$44K |
|
331
Unity
U
$19.2B
| $44K | 0.02% |
2,000
-1,456
| -42% | -$32K |
|
332
Warrior Met Coal
HCC
$3.05B
| $43K | 0.02% |
+800
| New | +$43K |
|
333
BILL Holdings
BILL
$5.1B
| $42K | 0.02% |
500
-295
| -37% | -$24.8K |
|
334
Coherent
COHR
$15.4B
| $42K | 0.02% |
450
+154
| +52% | +$14.4K |
|
335
Sprinklr
CXM
$1.93B
| $42K | 0.02% |
+5,000
| New | +$42K |
|
336
Maplebear
CART
$11.9B
| $40K | 0.02% |
972
-250
| -20% | -$10.3K |
|
337
iShares MSCI Brazil ETF
EWZ
$5.46B
| $40K | 0.02% |
+1,799
| New | +$40K |
|
338
Structure Therapeutics
GPCR
$1.2B
| $40K | 0.02% |
+1,500
| New | +$40K |
|
339
VICI Properties
VICI
$35.5B
| $40K | 0.02% |
1,400
| – | – |
|
340
XP
XP
$9.76B
| $40K | 0.02% |
+3,400
| New | +$40K |
|
341
Criteo
CRTO
$1.24B
| $39K | 0.02% |
1,000
| – | – |
|
|
TE
342
T1 Energy Inc.
TE
$309M
| $39K | 0.02% |
+15,200
| New | +$39K |
|
343
Maravai LifeSciences
MRVI
$353M
| $38K | 0.02% |
7,000
+6,000
| +600% | +$32.6K |
|
344
Protagonist Therapeutics
PTGX
$3.5B
| $38K | 0.02% |
+1,000
| New | +$38K |
|
345
US Bancorp
USB
$75.7B
| $38K | 0.02% |
+800
| New | +$38K |
|
346
Comerica
CMA
$8.83B
| $37K | 0.02% |
600
| – | – |
|
|
EOD
347
Allspring Global Dividend Opportunity Fund
EOD
$248M
| $37K | 0.02% |
7,500
| – | – |
|
348
Crown Castle
CCI
$40.9B
| $36K | 0.02% |
400
+300
| +300% | +$27K |
|
349
Hertz
HTZ
$1.86B
| $36K | 0.02% |
+9,989
| New | +$36K |
|
350
Digital Realty Trust
DLR
$55B
| $35K | 0.02% |
+200
| New | +$35K |
|